Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM
Phase 2
Recruiting
- Conditions
- Glioblastoma
- Interventions
- First Posted Date
- 2017-01-02
- Last Posted Date
- 2021-05-11
- Lead Sponsor
- Johnpro Biotech, Inc.
- Target Recruit Count
- 288
- Registration Number
- NCT03008148
- Locations
- 🇨🇳
Taipei Veterans General Hospital, Taipei City, Taiwan
🇨🇳Tri-Service General Hospital, Taipei City, Taiwan
© Copyright 2025. All Rights Reserved by MedPath